On February 18, 2025, Atrium Research analyst Nicholas Cortellucci maintained a Buy rating and CA$0.90 target price on Sabio Holdings (SBIO:TSXV, SABOF:OTC), citing strong preliminary Q4 2024 results driven by growth in ad-supported streaming and expanded household graph coverage.
Sabio reported preliminary Q4 2024 revenue of US$18.0-18.2 million, representing 42% year-over-year growth and exceeding the analyst's estimate of US$16.4 million. Political revenue contributed US$2.4-2.5 million to the quarter's results. Gross margins came in at 59-61%, slightly below the estimated 62%. Adjusted EBITDA was $2.6-2.8 million (15% margin), in line with expectations of US$2.7 million. The company ended Q4 with US$3.3 million in cash and US$5.2 million drawn on its revolving credit facility.
For the full year 2024, Sabio achieved revenue of US$49.3-49.5 million, representing 37% year-over-year growth with approximately 60% gross margins. Adjusted EBITDA reached US$3.6-3.8 million (7-8% margin), a significant improvement from negative US$1.8 million in 2023. The company maintained strong customer retention at 85% throughout the year.
A significant development was the expansion of App Science's household graph to 80 million households, up from the previous 55 million, which now represents 70% of U.S. streaming households. This broader coverage strengthens Sabio's value proposition to clients and creates additional opportunities for revenue growth.
The analyst identified several compelling merits for Sabio's investment. The U.S. streaming TV ad spend market is growing at a 15% CAGR, providing strong tailwinds for the company. Sabio has successfully reduced its dependence on cyclical political revenue through international expansion while also improving EBITDA margins following cost-cutting initiatives. The company maintains a strong Fortune 500 customer base with 90% recurring revenue. Management alignment is robust, with CEO Aziz Rahimtoola holding 46% ownership and the management team and board holding an additional 9%.
Looking ahead, Cortellucci projects 7% revenue growth in 2025, noting this would be "a major win for the stock, as the market continues to discount SBIO's business quality and growth." The CA$0.90 target price represents a 43% potential return from the share price at the time of the report of CA$0.63.
Want to be the first to know about interesting Technology investment ideas? Sign up to receive the FREE Streetwise Reports' newsletter. | Subscribe |
Important Disclosures:
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
For additional disclosures, please click here.
Disclosures for Atrium Research, Sabio Holdings, February 18, 2025
Analyst Certification Each authoring analyst of Atrium Research on this report certifies that (i) the recommendations and opinions expressed in this research accurately reflect the authoring analyst’s personal, independent and objective views about any and all of the designated securities discussed (ii) no part of the authoring analyst’s compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in the research, (iii) to the best of the authoring analyst’s knowledge, she/he is not in receipt of material non-public information about the issuer, (iv) the analyst does not own common shares, options, or warrants in the company under coverage, and (v) the analysts adhere to the CFA Institute guidelines for analyst independence.
About Atrium Research Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis. For further information on our team, please visit https://www.atriumresearch.ca/team.
General Information Atrium Research Corporation (ARC) has created and distributed this report. This report is based on information we considered reliable; we have not been provided with any material non-public information by the company (or companies) discussed in this report. We do not represent that this report is accurate or complete and it should not be relied upon as such; further any information in this report is subject to change without any formal or type of notice provided. Investors should consider this report as only one factor in their investment decisions; this report is not intended as a replacement for investor’s independent judgment. ARC is not an IIROC registered dealer and does not offer investment-banking services to its clients. ARC (and its employees) do not own, trade or have a beneficial interest in the securities of the companies we provide research services for and does not serve as an officer or Director of the companies discussed in this report. ARC does not make a market in any securities. This report is not disseminated in connection with any distribution of securities and is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. ARC does not make any warranties, expressed or implied, as to the results to be obtained from using this information and makes no express of implied warranties for particular use. Anyone using this report assumes full responsibility for whatever results they obtain. This does not constitute a personal recommendation or take into account any financial or investment objectives, financial situations or needs of individuals. This report has not been prepared for any particular individual or institution. Recipients should consider whether any information in this report is suitable for their particular circumstances and should seek professional advice. Past performance is not a guide for future results, future returns are not guaranteed, and loss of original capital may occur. Neither ARC nor any person employed by ARC accepts any liability whatsoever for any direct or indirect loss resulting from any use of its research or the information it contains. This report contains "forward looking" statements. Forward-looking statements regarding the Company and/or stock’s performance inherently involve risks and uncertainties that could cause actual results to differ from such forward-looking statements. Such statements involve a number of risks and uncertainties such as competition, technology shifts, market demand and the company’s (and management’s) ability to correctly forecast financial estimates; please see the company’s MD&A “Risk Factors” Section for a more complete discussion of company specific risks for the company discussed in this report. ARC is receiving a cash compensation from Sabio Holdings Inc. for 12-months of research coverage. ARC retains full editorial control over its research content. ARC does not have investment banking relationships and does not expect to receive any investment banking driven income. ARC reports are primarily disseminated electronically and, in some cases, printed form. Electronic reports are simultaneously available to all recipients in any form. Reprints of ARC reports are prohibited without permission. To receive future reports on covered companies please visit https://www.atriumresearch.ca/research or subscribe on our website. The information contained in this report is intended to be viewed only in jurisdictions where it may be legally viewed and is not intended for use by any person or entity in any jurisdiction where such use would be contrary to local regulations or which would require any registration requirement within such jurisdiction.